Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment

Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen

doi:10.1039/c6cs00592f

journal article Jan 01, 2017

Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment

Yunlu Dai

Can Xu Xiaolian Sun Xiaoyuan Chen

Chemical Society Reviews Vol. 46 No. 12 pp. 3830-3852 · Royal Society of Chemistry (RSC)

View at Publisher Save 10.1039/c6cs00592f

Abstract

Exploiting the tumour microenvironment can benefit the design of nanomaterials for enhanced therapeutic effectiveness.

Topics

No keywords indexed for this article. Browse by subject →

References

291

[1]

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Rafael Lozano, Mohsen Naghavi, Kyle Foreman et al.

The Lancet 2013 10.1016/s0140-6736(12)61728-0

[2]

Chen Chem. Rev. (2016) 10.1021/acs.chemrev.5b00148

[3]

Bioresponsive materials

Yue Lu, Alex A. Aimetti, Robert Langer et al.

Nature Reviews Materials 2016 10.1038/natrevmats.2016.75

[4]

De Crozals Nano Today (2016) 10.1016/j.nantod.2016.07.002

[5]

Petros Nat. Rev. Drug Discovery (2010) 10.1038/nrd2591

[6]

Jain Nat. Rev. Clin. Oncol. (2010) 10.1038/nrclinonc.2010.139

[7]

Misra Drug Discovery Today (2010) 10.1016/j.drudis.2010.08.006

[8]

Chung Acc. Chem. Res. (2013) 10.1021/ar300159f

[9]

Dai J. Am. Chem. Soc. (2013) 10.1021/ja410028q

[10]

Kumar Chem. Soc. Rev. (2015) 10.1039/c5cs00224a

[11]

Nguyen Acc. Chem. Res. (2015) 10.1021/acs.accounts.5b00316

[12]

Muthu Theranostics (2014) 10.7150/thno.8698

[13]

Cai J. Am. Chem. Soc. (2015) 10.1021/ja513034e

[14]

Feng Coord. Chem. Rev. (2016) 10.1016/j.ccr.2016.04.019

[15]

Janib Adv. Drug Delivery Rev. (2010) 10.1016/j.addr.2010.08.004

[16]

Bardhan Acc. Chem. Res. (2011) 10.1021/ar200023x

[17]

Jokerst Acc. Chem. Res. (2011) 10.1021/ar200106e

[18]

Ma Acc. Chem. Res. (2011) 10.1021/ar2000056

[19]

Park Adv. Funct. Mater. (2009) 10.1002/adfm.200801655

[20]

Yang Chem. Soc. Rev. (2015) 10.1039/c4cs00155a

[21]

Shin Chem. Soc. Rev. (2015) 10.1039/c4cs00345d

[22]

Lee Adv. Mater. (2013) 10.1002/adma.201300081

[23]

Ulbrich Chem. Rev. (2016) 10.1021/acs.chemrev.5b00589

[24]

Tredan J. Natl. Cancer Inst. (2007) 10.1093/jnci/djm135

[25]

McKeever Clin. J. Oncol. Nurs. (2013) 10.1188/13.cjon.490-495

[26]

Torchilin Adv. Drug Delivery Rev. (2011) 10.1016/j.addr.2010.03.011

[27]

K. Greish , in Cancer Nanotechnology: Methods and Protocols, ed. R. S. Grobmyer and M. B. Moudgil, Humana Press, Totowa, NJ, 2010, pp. 25–37, DOI: 10.1007/978-1-60761-609-2_3

[28]

Maeda Bioconjugate Chem. (2010) 10.1021/bc100070g

[29]

The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo

Hiroshi Maeda, Hideaki Nakamura, Jun Fang

Advanced Drug Delivery Reviews 2013 10.1016/j.addr.2012.10.002

[30]

Brannon-Peppas Adv. Drug Delivery Rev. (2012) 10.1016/j.addr.2012.09.033

[31]

Wilhelm Nat. Rev. Mater. (2016) 10.1038/natrevmats.2016.14

[32]

Mbeunkui Cancer Chemother. Pharmacol. (2009) 10.1007/s00280-008-0881-9

[33]

Balkwill J. Cell Sci. (2012) 10.1242/jcs.116392

[34]

Fukumura J. Cell. Biochem. (2007) 10.1002/jcb.21187

[35]

Albini Nat. Rev. Cancer (2007) 10.1038/nrc2067

[36]

Banchereau Nat. Rev. Immunol. (2005) 10.1038/nri1592

[37]

Noy Immunity (2014) 10.1016/j.immuni.2014.06.010

[38]

Khawar J. Controlled Release (2015) 10.1016/j.jconrel.2014.12.018

[39]

Junttila Nature (2013) 10.1038/nature12626

[40]

Mao Cancer Metastasis Rev. (2013) 10.1007/s10555-012-9415-3

[41]

Noguera Histol. Histopathol. (2012)

[42]

Lu J. Cell Biol. (2012) 10.1083/jcb.201102147

[43]

Mouw Nat. Rev. Mol. Cell Biol. (2014) 10.1038/nrm3902

[44]

Hida Cancer Sci. (2013) 10.1111/cas.12251

[45]

Cirri Cancer Metastasis Rev. (2012) 10.1007/s10555-011-9340-x

[46]

Shiga Cancers (2015) 10.3390/cancers7040902

[47]

Karagiannis Mol. Cancer Res. (2012) 10.1158/1541-7786.mcr-12-0307

[48]

Torsvik Cancer Treat. Rev. (2013) 10.1016/j.ctrv.2012.03.005

[49]

Orimo Cell (2005) 10.1016/j.cell.2005.02.034

[50]

Galon Science (2006) 10.1126/science.1129139

Showing 50 of 291 references

Cited By

869

Smart stimuli-responsive polymeric nanoparticles in precision cancer therapy: From tumor microenvironment triggers to controlled release

Runhe Zhu, Xinru Yu · 2026

Chemical Engineering Journal

Naphthalimide‐Based Type‐I Nano‐Photosensitizers for Enhanced Antitumor Photodynamic Therapy: H 2 S Synergistically Regulates PeT and Self‐Assembly

Huiyu Niu, Songnan Wang · 2025

Angewandte Chemie International Edi...

Tumor-specific theranostics with stimulus-responsive MRI nanoprobes: Current advances and future perspectives

Chongqing Wang, Yuelin Huang · 2025

Coordination Chemistry Reviews

Manganese-based nanoenzymes: from catalytic chemistry to design principle and antitumor/antibacterial therapy

Long Qiu, Zhenying Diao · 2025

Nanoscale

Polymeric Nanoparticles for Drug Delivery

Maximilian A. Beach, Umeka Nayanathara · 2024

Chemical Reviews

A comprehensive scrutinization on tamarind kernel powder-based derivatives and nanomaterials in modern research

Sakshi Saini, Jagram Meena · 2024

Nano-Structures & Nano-Objects

Transition-Metal-Based Nanozymes: Synthesis, Mechanisms of Therapeutic Action, and Applications in Cancer Treatment

Qinrui Fu, Chuang Wei · 2024

ACS Nano

Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy

Xueqiang Peng, Jianjun Fang · 2024

Acta Pharmaceutica Sinica B

Efficacy tumor therapeutic applications of stimuli-responsive block copolymer-based nano-assemblies

Rui Yang, Yu Chen · 2024

Heliyon

Carrier-Free Nanodrugs: From Bench to Bedside

Fang Fang, Xiaoyuan Chen · 2024

ACS Nano

Current advance of nanotechnology in diagnosis and treatment for malignant tumors

Bilan Wang, Shiqi Hu · 2024

Signal Transduction and Targeted Th...

Nanoparticle-Based Activatable MRI Probes for Disease Imaging and Monitoring

Yifan Fan, Yuanxi Zheng · 2023

Chemical & Biomedical Imaging

Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy

Qi He, Liming Zhou · 2023

Journal of Medicinal Chemistry

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment

Hailong Tian, Jiangjun Cao · 2023

Bone Research

Colorectal cancer therapy mediated by nanomedicines

Shaopeng Zhang, Peizhe Song · 2023

Chemical Communications

Application of molecular dynamics simulation in self-assembled cancer nanomedicine

Xueli Xu, Ao Liu · 2023

Biomaterials Research

Cancer nanomedicine

Sangeeta N. Bhatia, Xiaoyuan Chen · 2022

Nature Reviews Cancer

Tumor Microenvironment-Based Stimuli-Responsive Nanoparticles for Controlled Release of Drugs in Cancer Therapy

Weixin Zhou, Yujie Jia · 2022

Pharmaceutics

Engineering Macrophages via Nanotechnology and Genetic Manipulation for Cancer Therapy

Xiaoling Ding, Xinchen Sun · 2022

Frontiers in Oncology

Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy

Minlin Jiang, Keyi Jia · 2021

Acta Pharmaceutica Sinica B

Metrics

869

Citations

291

References

Details

Published: Jan 01, 2017
Vol/Issue: 46(12)
Pages: 3830-3852

Authors

Y

Yunlu Dai

Centre for Molecular Imaging and Translational Medicine; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics; School of Public Health; Xiamen University; Xiamen 361102

C

Can Xu

Laboratory of Molecular Imaging and Nanomedicine; National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health; Bethesda; USA

X

Xiaolian Sun

Centre for Molecular Imaging and Translational Medicine; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics; School of Public Health; Xiamen University; Xiamen 361102

X

Xiaoyuan Chen

Laboratory of Molecular Imaging and Nanomedicine; National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health; Bethesda; USA

Funding

National Institute of Biomedical Imaging and Bioengineering Award: ZIA EB000073

Cite This Article

Yunlu Dai, Can Xu, Xiaolian Sun, et al. (2017). Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment. Chemical Society Reviews, 46(12), 3830-3852. https://doi.org/10.1039/c6cs00592f

Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment

You May Also Like